This project will use high-resolution solid-state nuclear magnetic resonance (NMR) to characterize the conformational changes which accompany the mineralization of elastin in the heritable vascular and dermal disorder called pseudoxanthoma elasticum (PXE). The normal elastic fiber lends resiliency to vertebrate tissues, such as the skin and blood vessels. Its major protein component is elastin, which imparts elasticity to these tissues. Elastin is an insoluble, amorphous, and extensively crosslinked biopolymer, and there are no high-resolution crystallographic or solution NMR structures for this protein. Changes in elastic fiber morphology have been associated with the loss of elasticity in heritable and acquired disorders such as Marfan syndrome, supravalvular aortic stenosis, and aortic aneurysms. And, recent work by other laboratories strongly suggests that the calcification of the elastic fibers in PXE patients is a secondary consequence of a primary alteration in the structure and/or assembly of elastin. Therefore, we propose that PXE effects the introduction of new components or abnormal concentrations of typical components in elastic tissue. The abnormal chemical conditions induce conformational changes of elastin, and it is this abnormal state which undergoes mineralization. To obtain the most definitive descriptions of structural changes to elastin on the molecular level, high-resolution solid-state NMR spectroscopy will be utilized. These studies will identify the structural differences between normal elastin and several calcified states, as produced in well-defined chemical conditions. And, the characterization of the abnormal elastin, as found in the tissue of a PXE patient, will be indicative of the conditions which accompany, or even induce, mineralization.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
1P20RR016453-01
Application #
6549000
Study Section
Special Emphasis Panel (ZRR1)
Project Start
2001-09-24
Project End
2006-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Hawaii
Department
Type
DUNS #
121911077
City
Honolulu
State
HI
Country
United States
Zip Code
96822
Jansen, Chad; Speck, Mark; Greineisen, William E et al. (2017) Transcriptional and Functional Plasticity Induced by Chronic Insulin Exposure in a Mast Cell-Like Basophilic Leukemia Cell Model. J Immunobiol 2:
Pomozi, Viola; Brampton, Christopher; Szeri, Flóra et al. (2017) Functional Rescue of ABCC6 Deficiency by 4-Phenylbutyrate Therapy Reduces Dystrophic Calcification in Abcc6-/- Mice. J Invest Dermatol 137:595-602
Baumer, Yvonne; McCurdy, Sara; Weatherby, Tina M et al. (2017) Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis. Nat Commun 8:1129
Doe, Jinger; Kaindl, Angela M; Jijiwa, Mayumi et al. (2017) PTRH2 gene mutation causes progressive congenital skeletal muscle pathology. Hum Mol Genet 26:1458-1464
Wilcox, Christie L; Headlam, Jasmine L; Doyle, Thomas K et al. (2017) Assessing the Efficacy of First-Aid Measures in Physalia sp. Envenomation, Using Solution- and Blood Agarose-Based Models. Toxins (Basel) 9:
Yanagihara, Angel Anne; Wilcox, Christie L (2017) Cubozoan Sting-Site Seawater Rinse, Scraping, and Ice Can Increase Venom Load: Upending Current First Aid Recommendations. Toxins (Basel) 9:
Doyle, Thomas K; Headlam, Jasmine L; Wilcox, Christie L et al. (2017) Evaluation of Cyanea capillata Sting Management Protocols Using Ex Vivo and In Vitro Envenomation Models. Toxins (Basel) 9:
Yanagihara, Angel A; Wilcox, Christie; King, Rebecca et al. (2016) Experimental Assays to Assess the Efficacy of Vinegar and Other Topical First-Aid Approaches on Cubozoan (Alatina alata) Tentacle Firing and Venom Toxicity. Toxins (Basel) 8:
Hartmann, Bianca; Wai, Timothy; Hu, Hao et al. (2016) Homozygous YME1L1 mutation causes mitochondriopathy with optic atrophy and mitochondrial network fragmentation. Elife 5:
Rose, Aaron H; Huang, Zhi; Mafnas, Chrisy et al. (2015) Calpain-2 Inhibitor Therapy Reduces Murine Colitis and Colitis-associated Cancer. Inflamm Bowel Dis 21:2005-15

Showing the most recent 10 out of 118 publications